These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Malignant hyperthermia and central core disease causative mutations in Swedish patients. Broman M, Islander G, Müller CR, Ranklev-Twetman E. Acta Anaesthesiol Scand; 2007 Jan; 51(1):50-3. PubMed ID: 17081152 [Abstract] [Full Text] [Related]
6. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family. Steinfath M, Seranski P, Singh S, Fiege M, Wappler F, Schulte Am Esch J, Scholz J. Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752 [Abstract] [Full Text] [Related]
7. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S, Matschke J, Schulte Am Esch J. Anesthesiology; 2001 Jan; 94(1):95-100. PubMed ID: 11135728 [Abstract] [Full Text] [Related]
11. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P, Reyford H, Lunardi J. Anesthesiology; 2002 Nov; 97(5):1067-74. PubMed ID: 12411788 [Abstract] [Full Text] [Related]